Zobrazeno 1 - 7 of 7 pro vyhledávání: '"Myriam Bouillette-Marussig"'
1
Akademický článek
GTL001, a bivalent therapeutic vaccine against human papillomavirus 16 and 18, induces antigen-specific CD8+ T cell responses leading to tumor regression.
Autor: Michaël Esquerré, Myriam Bouillette-Marussig, Anne Goubier, Marie Momot, Christophe Gonindard, Hélène Keller, Astrid Navarro, Marie-Christine Bissery
Publikováno v: PLoS ONE, Vol 12, Iss 3, p e0174038 (2017)
BACKGROUND:Prophylactic vaccines are available for women and girls not yet infected with HPV, but women already infected with HPV need a treatment to prevent progression to high-grade cervical lesions and cancer. GTL001 is a bivalent therapeutic vacc
Externí odkaz: https://doaj.org/article/8305acf6ec0f41e79dc46987357dfe75
Zobrazit plný text záznamu
6
GTL001, a bivalent therapeutic vaccine against human papillomavirus 16 and 18, induces antigen-specific CD8+ T cell responses leading to tumor regression
Autor: Myriam Bouillette-Marussig, Astrid Navarro, Anne Goubier, Christophe Gonindard, Michael Esquerre, Marie Momot, Marie-Christine Bissery, Hélène Keller
Publikováno v: PLoS ONE
PLoS ONE, Vol 12, Iss 3, p e0174038 (2017)
Background Prophylactic vaccines are available for women and girls not yet infected with HPV, but women already infected with HPV need a treatment to prevent progression to high-grade cervical lesions and cancer. GTL001 is a bivalent therapeutic vacc
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a686f5da59de7087dcee1f34e0bd17e
https://pubmed.ncbi.nlm.nih.gov/28301611
Zobrazit plný text záznamu
7
GTL001, a therapeutic vaccine for women infected with human papillomavirus 16 or 18 and normal cervical cytology : results of a phase I clinical trial
Autor: Marie-Christine Bissery, Myriam Bouillette-Marussig, Annick Hens, Nathalie Cools, Anne Goubier, Benedikt Timmerman, Pierre Van Damme, Herman Goossens, Ilse De Coster, Thierry Hercend, Christophe E. Depuydt, Viggo Van Tendeloo
Publikováno v: Clinical cancer research
Purpose: Women infected with human papillomavirus (HPV) with normal cytology to mild abnormalities currently have no treatment options other than watchful waiting or surgery if high-grade cervical lesions or cancer develop. A therapeutic vaccine woul
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c96a7be5ed1f95582252f435c30c5c99
https://hdl.handle.net/10067/1356630151162165141
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje